These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38040765)

  • 21. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
    Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
    J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.
    Yang R; Tang J; Kuang M; Liu H
    Ann Med; 2023 Dec; 55(1):276-284. PubMed ID: 36594446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
    Wang PT; Huang YB; Lin MY; Chuang PF; Hwang SJ
    Kaohsiung J Med Sci; 2012 Sep; 28(9):477-83. PubMed ID: 22974666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.
    Omae K; Ogawa T; Nitta K
    Heart Vessels; 2010 May; 25(3):203-8. PubMed ID: 20512447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population.
    Zheng CM; Wang JY; Chen TT; Wu YC; Wu YL; Lin HT; Chiu SP; Chang TJ; Zheng JQ; Chu NF; Lin YM; Su SL; Lu KC; Chen JS; Sung FC; Lee CT; Yang Y; Hwang SJ; Wang MC; Hsu YH; Chiou HY; Kao S; Wu MY; Lin YF
    Sci Rep; 2019 Feb; 9(1):2694. PubMed ID: 30804406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
    Jain AK; Cuerden MS; McLeod I; Hemmelgarn B; Akbari A; Tonelli M; Quinn RR; Oliver MJ; Garg AX
    Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current use of angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors for hypertension in patients with chronic kidney disease with proteinuria: a cross-sectional study based on real-world data.
    Tada K; Nakano Y; Takahashi K; Hiyamuta H; Watanabe M; Ito K; Yasuno T; Abe M; Satoh A; Kawazoe M; Maeda T; Yoshimura C; Kosuke M; Arima H
    Hypertens Res; 2024 Sep; ():. PubMed ID: 39300299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
    Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
    BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
    Doege C; Luedde M; Kostev K
    JAMA Neurol; 2022 Dec; 79(12):1296-1302. PubMed ID: 36251288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.
    Liu D; Wang LN; Li HX; Huang P; Qu LB; Chen FY
    J Int Med Res; 2017 Apr; 45(2):383-398. PubMed ID: 28415944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal outcomes of diabetic patients treated with combination therapy of ACE inhibitors plus either thiazide diuretics or calcium channel blockers: comparative retrospective cohort study in Northwestern Ethiopia.
    Netere AK; Muhammad EA; Asres MS; Teklie MT
    BMJ Open; 2021 Nov; 11(11):e048442. PubMed ID: 34824108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effects of calcium channel blockers and renin-angiotensin-aldosterone system inhibitors on changes in the estimated glomerular filtration rate in patients with polycystic kidney disease.
    Mitobe M; Yoshida T; Sugiura H; Shiohira S; Shimada K; Nitta K; Tsuchiya K
    Clin Exp Nephrol; 2010 Dec; 14(6):573-7. PubMed ID: 20700620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
    JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
    Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
    Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effectiveness of antihypertensive drugs in nondiabetic patients with hypertension: A population-based study.
    Machado MAÁ; de Moura CS; Wang Y; Danieli C; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
    J Clin Hypertens (Greenwich); 2017 Oct; 19(10):999-1009. PubMed ID: 28755451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
    Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.